1. Stocks
  2. Vijaya Diagnostic Centre Ltd.
  3. Swot
swot-logo

Vijaya Diagnostic Centre Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Vijaya Diagnostic Centre Ltd. has 22 Strengths, 8 Weaknesses, 2 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Expensive Stars (DVM)

Strong Momentum: Price above short, medium and long term moving averages

Consistent Highest Return Stocks over Five Years - Nifty500

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Company with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Company with No Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Company with Zero Promoter Pledge

Stock gained more than 20% in one month

RSI indicating price strength

MACD crossed above zero line previous end of day

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE

PEG greater than Industry PEG

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)